Literature DB >> 29319219

Osthole induces human nasopharyngeal cancer cells apoptosis through Fas-Fas ligand and mitochondrial pathway.

Pei-Ying Liu1, Dun-Cheng Chang2, Yu-Sheng Lo2, Yi-Ting Hsi2, Chia-Chieh Lin2, Yi-Ching Chuang2, Shu-Hui Lin3, Ming-Ju Hsieh2,4, Mu-Kuan Chen1.   

Abstract

Nasopharyngeal carcinoma (NPC) is endemic in Southern China and Southeast Asia. The present study investigated the activity of osthole in suppressing NPC along with the underlying mechanism. Cell growth inhibition was measured using the MTT assay. Apoptosis was detected through 4',6-diamidino-2-phenylindole staining and flow cytometry. Western blotting was used to identify the signaling pathway. Osthole markedly inhibited cell proliferation and induced apoptosis in the NPC cell line. Western blotting results revealed the increased activation of caspases 3, 8, and 9 and poly (ADP-ribose) polymerase. Osthole treatment significantly reduced the expression of the antiapoptotic protein Bcl-2 and increased the expression of the proapoptotic proteins Bax, Bak, BimL, BimS, and t-Bid. Osthole treatment also increased the expression of Fas, FADD, TNF-R1, TNF-R2, DcR2, RIP, and DR5. In addition, osthole treatment significantly increased the expression levels of phosphorylated ERK1/2 and JNK1/2. These results suggested that osthole exerts cytotoxic effects on NPC cell lines mainly through apoptosis mediated by the Fas-Fas ligand and mitochondrial pathway. Osthole could be a potential anticancer agent for NPC.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Fas ligand; apoptosis; mitochondrial; nasopharyngeal carcinoma; osthole

Mesh:

Substances:

Year:  2018        PMID: 29319219     DOI: 10.1002/tox.22530

Source DB:  PubMed          Journal:  Environ Toxicol        ISSN: 1520-4081            Impact factor:   4.119


  7 in total

1.  Effect of combined treatment with lobaplatin and osthole on inducing apoptosis and inhibiting proliferation in human breast cancer MDA-MB-231 cells.

Authors:  Nan Liu; Hao Tian; Guoduo Zhang; Na Sun; Shumei Wang
Journal:  Med Oncol       Date:  2021-11-27       Impact factor: 3.064

2.  Osthole enhances the immunosuppressive effects of bone marrow-derived mesenchymal stem cells by promoting the Fas/FasL system.

Authors:  Yang Yu; Meng Chen; Shiyao Yang; Bingyi Shao; Liang Chen; Lei Dou; Jing Gao; Deqin Yang
Journal:  J Cell Mol Med       Date:  2021-03-21       Impact factor: 5.310

3.  Osthole sensitizes with radiotherapy to suppress tumorigenesis of human nasopharyngeal carcinoma in vitro and in vivo.

Authors:  Lin Peng; Yi-Teng Huang; Jian Chen; Yi-Xuan Zhuang; Fan Zhang; Jiong-Yu Chen; Li Zhou; Dong-Hong Zhang
Journal:  Cancer Manag Res       Date:  2018-11-08       Impact factor: 3.989

4.  Osthole Inhibits Breast Cancer Progression through Upregulating Tumor Suppressor GNG7.

Authors:  Jie Mei; Tiejun Wang; Shaojie Zhao; Yan Zhang
Journal:  J Oncol       Date:  2021-02-27       Impact factor: 4.375

5.  Osthole improves collagen-induced arthritis in a rat model through inhibiting inflammation and cellular stress.

Authors:  Renguo Xu; Zhen Liu; Jiande Hou; Tao Huang; Ming Yang
Journal:  Cell Mol Biol Lett       Date:  2018-05-02       Impact factor: 5.787

6.  The combined usage of Matrine and Osthole inhibited endoplasmic reticulum apoptosis induced by PCV2.

Authors:  Yinlan Xu; Panpan Sun; Shuangxiu Wan; Jianhua Guo; Xiaozhong Zheng; Yaogui Sun; Kuohai Fan; Wei Yin; Na Sun; Hongquan Li
Journal:  BMC Microbiol       Date:  2020-10-12       Impact factor: 3.605

7.  Osthole induces necroptosis via ROS overproduction in glioma cells.

Authors:  Mengjie Huangfu; Riming Wei; Juan Wang; Jianli Qin; Dan Yu; Xiao Guan; Xumei Li; Minglei Fu; Haiping Liu; Xu Chen
Journal:  FEBS Open Bio       Date:  2021-01-19       Impact factor: 2.792

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.